Literature DB >> 23813135

Non-invasive assessment of liver fibrosis with transient elastography (FibroScan®): applying the cut-offs of M probe to XL probe.

Grace Lai-Hung Wong1, Julien Vergniol, Peter Lo, Vincent Wai-Sun Wong, Juliette Foucher, Brigitte Le Bail, Paul Cheung-Lung Choi, Faiza Chermak, Kwong-Sak Leung, Wassil Merrouche, Henry Lik-Yuen Chan, Victor de Lédinghen.   

Abstract

UNLABELLED: BACKGROUND AND RATIONALE FOR THE STUDY: Limited studies have aimed to define the cut-offs of XL probe (XL cut-offs) for different stages of liver fibrosis, whereas those of M probe (M cut-offs) may not be applicable to XL probe. We aimed to derive appropriate XL cut-offs in overweight patients. Patients with liver stiffness measurement (LSM) by both probes were recruited. XL cut-offs probe for corresponding M cut-offs were derived from an exploratory cohort, and subsequently validated in a subgroup patients also underwent liver biopsy. The diagnostic accuracy of XL cut-offs to diagnose advanced fibrosis was evaluated.
RESULTS: Total 517 patients (63% male, mean age 58) who had reliable LSM by both probes were included in the exploratory cohort. There was a strong correlation between the LSM by M probe (LSM-M) and LSM by XL probe (LSM-XL) (r² = 0.89, p < 0.001). A decision tree using LSM-XL was learnt to predict the 3 categories of LSM-M (< 6.0kPa, 6.0-11.9kPa and ≥ 12.0kPa), and XL cut-offs at 4.8kPa and 10.7kPa were identified. These cut-offs were subsequently validated in a cohort of 147 patients who underwent liver biopsy. The overall accuracy was 89% among 62 patients whose LSM-XL < 4.8kPa or ≥ 10.7kPa. These cut-offs would have avoided under-staging of fibrosis among patients with body mass index (BMI) > 25-30 kg/m2 but not > 30 kg/m2.
CONCLUSIONS: XL cut-offs at 4.8kPa and 10.7kPa were the best estimates of 6.0kPa and 12.0kPa of M probe for patients with BMI > 25-30 kg/m2. Patients with BMI > 30 kg/m² might use M probe cut-offs for XL probe.

Entities:  

Mesh:

Year:  2013        PMID: 23813135

Source DB:  PubMed          Journal:  Ann Hepatol        ISSN: 1665-2681            Impact factor:   2.400


  10 in total

Review 1.  Liver elastography, comments on EFSUMB elastography guidelines 2013.

Authors:  Xin-Wu Cui; Mireen Friedrich-Rust; Chiara De Molo; Andre Ignee; Dagmar Schreiber-Dietrich; Christoph F Dietrich
Journal:  World J Gastroenterol       Date:  2013-10-14       Impact factor: 5.742

Review 2.  Ultrasound Elastography and MR Elastography for Assessing Liver Fibrosis: Part 1, Principles and Techniques.

Authors:  An Tang; Guy Cloutier; Nikolaus M Szeverenyi; Claude B Sirlin
Journal:  AJR Am J Roentgenol       Date:  2015-04-23       Impact factor: 3.959

3.  Association of fetuin B with markers of liver fibrosis in nonalcoholic fatty liver disease.

Authors:  Thomas Ebert; Nicolas Linder; Alexander Schaudinn; Harald Busse; Joachim Berger; Ralf Lichtinghagen; Volker Keim; Johannes Wiegand; Thomas Karlas
Journal:  Endocrine       Date:  2017-09-15       Impact factor: 3.633

4.  Appropriate use of virtual touch quantification and FibroScan M and XL probes according to the skin capsular distance.

Authors:  Erina Kumagai; Keiko Korenaga; Masaaki Korenaga; Masatoshi Imamura; Misuzu Ueyama; Yoshihiko Aoki; Masaya Sugiyama; Kazumoto Murata; Naohiko Masaki; Tatsuya Kanto; Masashi Mizokami; Sumio Watanabe
Journal:  J Gastroenterol       Date:  2015-10-13       Impact factor: 7.527

5.  Hepatic MR Elastography: Clinical Performance in a Series of 1377 Consecutive Examinations.

Authors:  Meng Yin; Kevin J Glaser; Jayant A Talwalkar; Jun Chen; Armando Manduca; Richard L Ehman
Journal:  Radiology       Date:  2015-07-08       Impact factor: 11.105

6.  Reduced hepatic steatosis is associated with higher risk of hepatocellular carcinoma in chronic hepatitis B infection.

Authors:  Lung-Yi Mak; Rex Wan-Hin Hui; James Fung; Fen Liu; Danny Ka-Ho Wong; Bofei Li; Ka-Shing Cheung; Man-Fung Yuen; Wai-Kay Seto
Journal:  Hepatol Int       Date:  2021-06-21       Impact factor: 6.047

7.  Transient elastography and APRI score: looking at false positives and false negatives. Diagnostic performance and association to fibrosis staging in chronic hepatitis C.

Authors:  L C Mendes; P A Ferreira; N Miotto; L Zanaga; E Gonçales; M S Lazarini; F L Gonçales; R S B Stucchi; A G Vigani
Journal:  Braz J Med Biol Res       Date:  2016-08-01       Impact factor: 2.590

Review 8.  Feasibility and Efficacy of Transient Elastography using the XL probe to diagnose liver fibrosis and cirrhosis: A meta-analysis.

Authors:  Bingqing Xia; Fengyan Wang; Mireen Friedrich-Rust; Fang Zhou; Jingyu Zhu; Hua Yang; Weishan Ruan; Zhirong Zeng
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.889

9.  A Pragmatic Approach Identifies a High Rate of Nonalcoholic Fatty Liver Disease With Advanced Fibrosis in Diabetes Clinics and At-Risk Populations in Primary Care.

Authors:  PreyaJanubhai Patel; Fabrina Hossain; Leigh Ula Horsfall; Xuan Banh; Kelly Lee Hayward; Suzanne Williams; Tracey Johnson; Anne Bernard; Nigel Neil Brown; Guy Lampe; Lyndall Buck; Nivene Saad; Anthony William Russell; Patricia Casarolli Valery; Katharine Margaret Irvine; Andrew Donald Clouston; Katherine Anne Stuart; William Rosenberg; Elizabeth Ellen Powell
Journal:  Hepatol Commun       Date:  2018-08-06

10.  The Utility and Diagnostic Accuracy of Transient Elastography in Adults with Morbid Obesity: A Prospective Study.

Authors:  Ahmad Hassan Ali; Alhareth Al Juboori; Gregory F Petroski; Alberto A Diaz-Arias; Majid M Syed-Abdul; Andrew A Wheeler; Rama R Ganga; James B Pitt; Nicole M Spencer; Ghassan M Hammoud; R Scott Rector; Elizabeth J Parks; Jamal A Ibdah
Journal:  J Clin Med       Date:  2022-02-23       Impact factor: 4.964

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.